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HIPK2Posttranslational modiﬁcation of proteins by lysine acetylation regulates many biological processes ranging
from signal transduction to chromatin compaction. Here we identify the acetyl-transferases CBP/p300,
Tip60 and PCAF as new substrates for the ubiquitin E3 ligases SIAH1 and SIAH2. While CBP/p300 can undergo
ubiquitin/proteasome-dependent degradation by SIAH1 and SIAH2, the two other acetyl-transferases are ex-
clusively degraded by SIAH2. Accordingly, SIAH-deﬁcient cells show enhanced protein acetylation, thus re-
vealing SIAH proteins as indirect regulators of the cellular acetylation status. Functional experiments show
that Tip60/PCAF-mediated acetylation of the tumor suppressor p53 is antagonized by the p53 target gene
SIAH2 which mediates ubiquitin/proteasome-mediated degradation of both acetyl-transferases and conse-
quently diminishes p53 acetylation and transcriptional activity. The p53 kinase HIPK2 mediates hierarchical
phosphorylation of SIAH2 at 5 sites, which further boosts its activity as a ubiquitin E3 ligase for several sub-
strates and therefore dampens the late p53 response.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The attachment of K48-branched ubiquitin chains to target pro-
teins leads to their proteasomal degradation and thus controls their
turnover rate. Ubiquitination is an ATP-dependent process that re-
quires a complex machinery consisting of E1 ubiquitin-activating,
E2 ubiquitin-conjugating and E3 ubiquitin-ligating enzymes [1].
Ubiquitin E3 ligases fall into several groups including the largest
group of RING (Really Interesting New Gene) ﬁnger and RING
ﬁnger-related E3s [2]. The RING family of ubiquitin E3 ligases also
comprises the SIAH (seven in absentia) family of E3 ligases. The
human genome encodes SIAH1 and the highly homologous SIAH2
protein. In mice a duplication of Siah1 created the Siah1a and Siah1b
alleles [3]. SIAH1 and SIAH2 proteins have a largely divergent
N-terminal part, but are highly conserved in the RING domain and
C-terminal substrate-binding domain. The SIAH proteins interact
with a large list of cytosolic and nuclear proteins including transcrip-
tional repressors such as tramtrack and nuclear receptor co-repressor
(NCoR), the coactivator BOB/OBF-1, the histone methyltransferase
SUV39H1 and the transcription elongation factor ELL2 [4–7]. The
long list of SIAH-regulated signaling proteins also implies SIAH pro-
teins in a variety of biological processes such as the regulation of
the hypoxic response, Ras-mediated signaling and cell death [8].+49 641 9947589.
i-giessen.de (M.L. Schmitz).
rights reserved.Transcription of the human SIAH1 and SIAH2 encoding genes can be
induced by p53 [9–11]. On the other hand, SIAH proteins can modu-
late the p53 response by ubiquitin/proteasome-dependent degrada-
tion of p53-regulating enzymes such as HBX or the serine/threonine
kinase HIPK2 [12,13].
Regulation of SIAH1 and SIAH2 protein function is achieved by
several mechanisms including inducible expression, differential for-
mation of homodimeric or heterodimeric complexes and also by
phosphorylation. Phosphorylation of murine Siah2 at Thr24 and
Ser29 increases its ability to degrade its substrate PHD3 [14]. Further-
more, phosphorylation of SIAH1 at Ser19 [11] or phosphorylation of
SIAH2 at positions 26, 28 and 68 and further unknown sites [12] di-
minishes the association with HIPK2.
The evolutionary conserved kinase HIPK2 has the ability to phos-
phorylate p53 at Ser46, thus facilitating the CBP (CREB binding
protein)-mediated acetylation of p53 at Lys382 which in turn pro-
motes p53-dependent gene expression [15]. Lys382 is only one of
nine different acetylation sites that have been described for the
tumor suppressor p53. Acetylation of p53 is a versatile mechanism
to activate its function, as acetylated p53 prevents degradative
ubiquitination at the same lysines, inhibits the formation of repres-
sive HDM2/HDMX complexes and allows the recruitment of cofactors
to direct promoter-speciﬁc activation of p53 transcriptional activity
[16]. The six lysine residues in the C-terminal regulatory domains of
p53 are acetylated by the lysine (K)-acetyl-transferases (KATs) CBP
and the highly homologous p300 protein. However, p53 is also
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is acetylated by the PCAF (P300/CBP-associated factor) and Lys120
is modiﬁed by Tip60 (Tat-interactive protein 60 kD) [17,18].
Here we describe the identiﬁcation of the KATs CBP/p300, Tip60
and PCAF as further substrates for the SIAH proteins. While CBP/
p300 was degraded by both SIAH variants, Tip60 and PCAF were
only degraded by SIAH2. Cells lacking the Siah1a/Siah2 genes have
more acetylated proteins and functional assays revealed that an im-
portant role of SIAH2 for dampening the late p53 response. Full
induction of early p53 activity is ensured by HIPK2 mediated phos-
phorylation and Tip60/PCAF-dependent acetylation of p53. The late
p53 activity is restrained by HIPK2-mediated phosphorylation of
SIAH2 which in turn augments its ability to degrade both KATs and
thus leads to impaired p53 acetylation and transcriptional activity.
2. Materials and methods
2.1. Plasmids
The plasmids encoding Flag-SIAH2, Flag-SIAH2 RM, HA-SIAH1,
HA-SIAH1 RM, His-Ubiquitin, Flag-p53 [12], p53-luciferase [19] as
well as HA-HIPK2, HA-p300 and Flag-CBP [20] have been described.
Expression vectors for His-tagged p53 [21] (Dr. Jin Won Cho, Seoul),
HA-tagged Tip60 [22] (Dr. Saadi Khochbin, Grenoble) and HA-PCAF
[23] (Melanie Ott, Heidelberg) were kind gifts. The point mutated
versions of Flag-SIAH2 were generated using the QuikChange®
site-directed mutagenesis kit (Stratagene).
2.2. Antibodies and reagents
Mouse monoclonal antibodies against Flag (M2) and Tubulin
(Tub2.1) were purchased from Sigma. Antibodies recognizing HA
(3F10) (Roche Applied Science), HA (Y-11), Actin (C-2) and CBP
(A-22) (Santa Cruz Biotechnology Inc.), ubiquitin (P4D1) and
acetyl-lysine (#9441) (Cell Signaling Technology) were from the
indicated suppliers. Rabbit polyclonal antibodies recognizing phos-
phorylated SIAH2 proteins were generated by PolyPeptide Group
(Strasbourg); the anti-phospho-SIAH2 (S28) antibodies were previous-
ly described [12]. Secondary HRP-coupled antibodies were obtained
from Dianova and MG132 was purchased from Sigma. Secondary
Cy-3-conjugated antibody (115-167-003) was purchased fromDianova
and FITC-conjugated antibody (sc-2359) was from Santa Cruz.
2.3. Cell culture, transient transfections and luciferase assays
HEK293T, H1299, U2OS, control MEFs and Siah1a−/−/Siah2−/−
MEFs were grown in DMEM supplemented with 10% (v/v) FCS,
2 mM L-glutamine and 1% (v/v) penicillin/streptomycin. HEK293T
and H1299 cells were transfected with Rotifect as described [24]. In
all transfections total DNA amounts were kept equal by adding
empty vector. Cells were lysed in 200 μl NP-40 buffer (50 mM Tris–
HCl (pH 8), 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 0.5 mM PMSF,
10 μg/ml aprotinin, 10 μg/ml leupeptin) and cleared by centrifuga-
tion. Ten microliters of the supernatant was mixed with 10 μl of lucif-
erase buffer and bioluminescence was immediately measured for 10 s
in a luminometer (Berthold DuoLumat LB 9501).
2.4. Cell lysis, co-immunoprecipitation and Western blotting
Native lysis was done upon addition of NP-40 buffer to the cell
pellets and incubation for 20 min on ice. Lysates were cleared by cen-
trifugation and proteins were either further analyzed by SDS-PAGE
andWestern blotting or by co-immunoprecipitation. Lysates were in-
cubated with 1 μg of antibody together with 25 μl of the protein A/G
PLUS agarose (Santa Cruz) that was blocked for 1 h at room temper-
ature in phosphate-buffered saline (PBS)/1% (w/v) BSA to avoid theoccurrence of nonspeciﬁc binding. After rotating for 4 h at 4 °C, the
beads were washed 5 times in NP40 lysis buffer. The precipitated pro-
teins were eluted by boiling in 2× SDS sample buffer for several mi-
nutes and were then further analyzed by Western blotting. Analysis
of protein acetylation was done upon addition of 1 μM of the HDAC
inhibitor trichostatin A (TSA) to lysis and washing buffers. Denaturing
lysis was done either by directly adding 1× SDS sample buffer or by
lysis of cells in guanidinium-HCl buffer, followed by puriﬁcation of
ubiquitinated proteins under denaturing conditions on Ni-NTA
sepharose as described [24].
2.5. Reverse transcription (RT)-PCR
While one portion of the cells was analyzed by Western blot anal-
ysis for protein expression, the remaining cells were lysed and total
RNA was extracted using the RNAeasy kit (Qiagen). One microgram
of RNA was used as a template for the production of cDNAs from
Oligo (dT)20 primers using the Superscript ﬁrst strand synthesis sys-
tem (Invitrogen). The various cDNAs encoding CBP, Tip60 and PCAF
were detected with speciﬁc primers in a PCR reaction between 28
and 32 cycles; the PCR products were detected after electrophoresis
on ethidium bromide-stained agarose gels.
2.6. Mass spectrometry
HEK293T cells transfected to express Flag-SIAH2 alone or combi-
nation with HA-HIPK2 were treated 12 h before lysis with 10 μM of
MG132. Cells were harvested and collected by centrifugation,
followed by lysis in IP buffer (50 mM Hepes pH 7.5, 50 mM NaCl,
1% (v/v) Triton X-100, 2 mM EDTA, 10 mM sodium ﬂuoride, 0.5 mM
sodium orthovanadate, 10 μg/ml leupeptine, 10 μg/ml aprotinin,
10 μg/ml aprotinin, 10 μg/ml leupeptin and 1 mM PMSF). The tagged
SIAH2 proteins were immunoprecipitated with anti-Flag M2 afﬁnity
gel (Sigma Aldrich) and the precipitated proteins were eluted by boil-
ing in 1.5× SDS sample buffer for 5 min. After separation of proteins
by SDS–PAGE, the protein bands were stained, followed by excision
of the SIAH2 bands and further analysis by RP-LC–MS/MS.
2.7. Protein structure prediction
Modeling of the SIAH2 protein structurewas performed by I-TASSER
[25,26] using the human amino acid sequence NM_005067.5. The
modeled structures were classiﬁed on the basis of C-score, TM-score
and root mean square deviation (RMSD), standard parameters used to
specify the closeness of the predictedmodel to the native structure. Sec-
ondary structure prediction of SIAH2 showed a C-score of−2.45, Exp.
TM-score of 0.43±0.14 and Exp. RMSD of 12.2±4.4. Validation of the
modeled SIAH2 structure was performed by superimposing it with the
crystal structure of SIAH1a (2AN6A). The study of the structural similar-
ity between proteinswas performed using the structure alignment pro-
gram TM-align [27]. SIAH2 model has an RMSD to target of 1.91 and
TM-score of 0.547. The validated structure was used to predict the
localization of the different HIPK2-phosphorylated residues. Figures
were produced using PyMOL (Version 1.3, Schrödinger, LLC, San
Diego, CA.).
2.8. Indirect immunoﬂuorescence staining
U2OS cells were seeded on cover slips and transfected to express
SIAH2 RM together with the various KATs as indicated. Cells were
washed twice with PBS and ﬁxed for 1 min with cold methanol/
aceton (1:1). After air-drying, the cells were rehydrated with PBS
and blocking was done with 10% (v/v) goat serum (Sigma) in PBS
for 60 min at room temperature. The primary and secondary anti-
bodies were incubated in 1% (v/v) goat serum overnight at 4 °C or
2 h at room temperature, respectively. After washing the cells several
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and cells were mounted with Kaiser's glycerol gelatine (Merck). Cells
were analyzed for intracellular localization of proteins with a Nikon
eclipse TE2000-E microscope.
3. Results
3.1. SIAH1 and SIAH2 degrade CBP and its related protein p300
As SIAH proteins have the ability to degrade HIPK2 [11,12,28], we
were interested to test whether SIAH proteins also destabilize HIPK2-
interacting proteins such as CBP which constitutively binds and acety-
lates HIPK2 [20]. To address this question, 293T cells were transfected
to express CBP along with increasing amounts of SIAH1 or a mutant
thereof which is mutated in a catalytically important cysteine contained
in the RINGdomain (SIAH1RM). Twodays later cellswere harvested andFlag-CBP
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2290 I. Grishina et al. / Biochimica et Biophysica Acta 1823 (2012) 2287–2296degradation process proceeds via the proteasome. The occurrence of
SIAH-mediated CBP ubiquitination was then tested upon coexpression
of CBP and the SIAH isoforms together with hexahistidine-tagged
ubiquitin. After enrichment of ubiquitinated proteins under denaturing
conditions on Ni-NTA columns, the ubiquitinated forms of CBP wererevealed by immunoblottingwith speciﬁc antibodies (Fig. 1D). These ex-
periments showed ubiquitination of CBP by both SIAH isoforms and a
higher ubiquitinating activity of SIAH2. To test whether SIAH-proteins
can also trigger degradation of the CBP-related protein p300, 293T cells
were transfected to express p300 alone or with increasing amount of
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p300 protein levels by immunoblotting (Fig. 1E). Similar to the CBP pro-
tein p300 was efﬁciently degraded upon expression of increasing
amounts of SIAH1 and also SIAH2 proteins.3.2. Tip60 and PCAF are exclusively degraded by SIAH2
As HIPK2 can also associate with Tip60 [29] we tested a potential
inﬂuence of SIAH1 and SIAH2 on Tip60 protein levels. Coexpression
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remained without any inﬂuence. As SIAH2 did not affect Tip60 mRNA
levels (Fig. 2A), these data show that Tip60 can be diminished selectively
by SIAH2. As HIPK2 contributes to PCAF-mediated p53 acetylation [30]
we extended the search for new SIAH substrates also to PCAF. Strikingly,
also the levels of the PCAF proteinwere strongly diminished in the pres-
ence of SIAH2 (Fig. 2B), but similar to Tip60 also PCAF was selectively
degraded by SIAH2. The SIAH2-mediated degradation of these two
KATswas largely abrogated in the presence ofMG132 (Fig. 2C), showing
that degradation of PCAF and Tip60 proceeds via the proteasome. Ac-
cordingly, SIAH2 expression promoted ubiquitination of PCAF (Fig. 2D)
and Tip60 (Fig. 2E), as revealed by coexpression of His-tagged ubiquitin
and Ni-NTA pull-down experiments.
Many ubiquitin E3 ligases such as SIAH2 can (at least transiently)
interact with their substrate proteins [12]. It was therefore relevant to
investigate the occurrence of SIAH2 binding to its substrate proteins
Tip60 andPCAF. To address this question, Tip60 and PCAFwere expressed
either alone or together with the SIAH2 RING domain mutant protein
SIAH2 RM, which is unable to degrade its interaction partners.
Co-immunoprecipitation experiments showed the occurrence of Tip60and PCAF in samples of immunoprecipitated SIAH2 RM (Fig. 3A), thus re-
vealing mutual interaction between this ubiquitin E3 ligase and its sub-
strate proteins. Subsequently we compared the intracellular localization
of the acetyltransferaseswith that of the SIAH2 protein by indirect immu-
noﬂuorescence. As the expression of endogenous SIAH2 is extremely low,
cells were transfected to express the HA-tagged acetyltransferases to-
gether with Flag-tagged SIAH2-RM in order to avoid degradation of
interacting proteins. While all four KATs were found exclusively in the
nucleus, SIAH2 showed a mainly perinuclear distribution in the cytosol
and only a minor fraction localized to the nucleus (Fig. 3B). These data
suggest that only a small fraction of the KATs colocalizes and interacts
with SIAH2, thus ensuring that not all proteins are degraded.
3.3. SIAH2-mediated control of KATs affects the acetylation status of p53
and further proteins
The p53 tumor suppressor has multiple important functions in the
cell, raising the need to control and specify its individual functions by
additional mechanisms such as acetylation. To compare the abilities
of Tip60 and PCAF to acetylate p53, cells were transfected to express
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Fig. 5. Functional characterization of HIPK2-mediated SIAH2 phosphorylation sites. The indicated expression plasmids for Flag-SIAH2 and its phosphorylation site mutants were
expressed alone or together with HA-HIPK2 in 293T cells. Cell lysates were analyzed by immunoblotting with the indicated phospho-speciﬁc antibodies for the occurrence of
site-speciﬁc SIAH2 phosphorylations. The position of a molecular weight marker is given in kDa; the asterisk highlights a non-speciﬁc band.
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Following immunoprecipitation of p53, Western blotting with an an-
tibody recognizing acetylated lysines showed that PCAF and Tip60
acetylate p53 to a comparable extent (Fig. 4A). In a next step it was
then interesting to test whether PCAF or Tip60-induced p53 acetyla-
tion can be regulated by SIAH2. Coexpression of this E3 ligase largely
abrogated PCAF- and Tip60-mediated p53 acetylation (Fig. 4B), thus
identifying SIAH2 as an additional protein that can inﬂuence the
p53 acetylation status, albeit in an indirect manner. To determine
the impact of SIAH2 on p53 acetylation-dependent transcription,
luciferase assays were performed (Fig. 4C). Expression vectors for
p53, both KATs and active/inactive SIAH2 were transfected into
p53-deﬁcient H1299 cells along with a p53-dependent luciferase
gene. While induction of gene expression by p53 was further aug-
mented by Tip60 or PCAF, coexpression of SIAH2 turned gene expres-
sion down to the levels reached upon expression of p53 alone. This
effect was strictly dependent on the integrity of the SIAH2 RING do-
main, showing that the ubiquitinating activity of SIAH2 is required
to dampen p53 acetylation and thus its transcriptional activity. Col-
lectively these experiments show that SIAH E3 ligases control the sta-
bility of several KATs, raising the possibility that they might have an
impact on the general acetylation status of the cell. To address this
question we compared the acetylation status of MEFs lacking the
Siah2 and Siah1a genes to that of control wildtype MEFs. Cells were
treated for 12 h with the broad-spectrum HDAC inhibitor trichostatin
A (TSA), followed by enrichment of acetylated proteins by immunopre-
cipitation with acetyl-speciﬁc antibodies and immunoblotting. Detec-
tion of acetylated proteins with pan-acetyl-lysine-speciﬁc antibodies
showed the occurrence of several additional bands representing acety-
lated proteins in the Siah1a−/−/Siah2−/− cells (Fig. 4D), thus revealing
that SIAH proteins can also indirectly control the acetylome.
3.4. HIPK2-mediated SIAH2 phosphorylation augments its activity as a
ubiquitin E3 ligase
The activity of SIAH2 proteins can be regulated by various mecha-
nisms including phosphorylation by the p53 kinase HIPK2 [12].However, these phosphorylation sites were incompletely mapped,
raising the need to identify more SIAH2 phosphorylation sites using
an unbiased approach. Towards this goal SIAH2 was expressed either
alone or together with HIPK2, followed by immunoprecipitation of
SIAH2 and denaturing SDS-PAGE. Bands representing SIAH2 were ex-
cised and phosphorylation sites were identiﬁed by mass spectrometry
(supplementary Fig. 1). This analysis conﬁrmed the published SIAH2
modiﬁcations at residues 26, 28 and 68, but also allowed the identiﬁ-
cation of Ser16 and Thr119 as new HIPK2-dependent phosphoryla-
tion sites (supplementary Fig. 2). HIPK2 phosphorylation sites are
typically ﬂanked by a proline, which is also the case for four (Thr26,
Ser28, Ser68 and Thr119) out of the ﬁve phosphosites identiﬁed
here. To conﬁrm HIPK2-mediated phosphorylation at these residues
by an independent experimental approach, speciﬁc SIAH2 antibodies
recognizing phosphorylated Ser16, Thr26, Ser68 and Thr119 were
raised. While the phospho-Ser28 antibody was previously described
[12], only the quality of the newly produced antibodies recognizing
phosphorylated Thr26, Ser68 and Thr119 was sufﬁcient to use them
for further experiments. To test the occurrence of SIAH2 phosphoryla-
tion, the E3 ligase was expressed either alone or together with HIPK2
and modiﬁcation of SIAH2 was determined with the different
modiﬁcation-speciﬁc antibodies. These experiments showed HIPK2-
mediated phosphorylation of SIAH2 at all 4 different sites (Fig. 5).
Mutation of the phosphorylated amino acids to alanine precluded rec-
ognition by the respective phospho-speciﬁc antibodies, thus ensuring
their speciﬁcity. The absent reactivity of the SIAH2 phospho-Thr26 anti-
body towards the SIAH2 S28A mutant is most probably due to
overlapping epitopes, but interestingly some other phosphorylations oc-
curred hierarchically (Fig. 5). SIAH2 phosphorylation at Ser68 was con-
stitutive and occurred also in the absence of overexpressed HIPK2.
Phosphorylation at Ser68 and Thr26 was absent after mutation of
Thr119 to Ala, suggesting that phosphorylation of Thr119 is required
for Ser68 modiﬁcation. Given the hierarchical occurrence of HIPK2-
mediated phosphorylations on SIAH2 it was then interesting to visualize
the relative localizations of the phosphorylation sites. As the structure of
SIAH2 is not known we generated a three-dimensional model using the
iterative threading assembly reﬁnement (I-TASSER) procedure [25,26].
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Fig. 6. Structure prediction for SIAH2. (A) Superposition of the crystal structure of SIAH1a (red) (residues 92–282, PDB entry 2AN6A) and the computationally predicted SIAH2
model (green). The study of the structural similarity between proteins was performed using the structure alignment program TM-align. SIAH2 model has an RMSD to target of
0.79 and TM-score of 0.585. The ﬁgure was produced using PyMOL (Version 1.3, Schrödinger, LLC, San Diego, CA.). The left part shows SIAH1a and SIAH2 as ribbon diagrams;
the right part shows the ribbon diagram of SIAH2 with a superimposed space-ﬁlling model. (B) Space-ﬁlling models of SIAH2 are shown from different angles; the phosphorylated
amino acids are highlighted in red. (C) Close-up of the patch containing phosphorylated Thr26, Ser28 and Thr119.
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SIAH1a (PDB 2AN6A) [31] showed the structural conservation of
the regions forming the substrate-binding domain (Fig. 6A). All 5
phosphorylation sites are not found in the region known to be direct-
ly involved in direct substrate recognition [32], but 4 of them (Ser16,
Thr26, Ser28 and Thr119) are found on one surface of SIAH2
(Fig. 6B). Three phosphorylated amino acids (Thr26, Ser28 and
Thr119) localize in close vicinity and form a narrow patch that
upon phosphorylation would be strongly negatively charged. The
priming phosphorylation site Thr119 is predicted to be at an exposed
position and protrudes from the surface (Fig. 6C). To investigate the
consequences of SIAH2 phosphorylation for its ability to degrade
substrate proteins, 293T cells were transfected to express Tip60
(Fig. 7A) and PCAF (Fig. 7B) along with increasing amounts of
SIAH2 wildtype, and SIAH2 mutants where all 5 phosphorylation
sites have been either mutated to alanine (SIAH2 5A) or in a
phosphorylation-mimicking fashion to aspartic acid (SIAH2 5D).
Subsequent analysis of Tip60 and PCAF levels showed an augmented
ability of the phosphomimetic SIAH2 5D mutant to degrade the KATs
(Fig. 7A, B), thus revealing that HIPK2-mediated phosphorylation of
SIAH2 stimulates its activity as an E3 ligase. It was then interesting to
seewhether SIAH2 5D also has an increased ability to degrade its kinaseHIPK2. A comparison between the wildtype and phosphomimetic
SIAH2 proteins showed that the increased activity of SIAH2 5D also oc-
curred for HIPK2 (Fig. 7C), providing a possible mechanism how exces-
sive SIAH2 phosphorylation is prevented.
4. Discussion
Here we identify SIAH proteins as ubiquitin E3 ligases targeting the
KATs CBP/p300, PCAF and Tip60. The KATs neither contain the consen-
sus sequence RPVAxVxPxxR which is contained in some of the SIAH
substrate proteins [33] nor display a signiﬁcant degree of sequence ho-
mologies. The KATs investigated here are typically contained in large
multisubunit complexes [34]. While Tip60 is one of the 18 subunits of
the NuA4 complex [35], PCAF associates with further subunits to form
the SAGA or the ATAC complexes [36]. It is presently not clear whether
SIAH proteins degrade free KATs outside from these complexes or
whether SIAH can be transiently recruited as a non-stoichiometric com-
ponent to these complexes. In any case, SIAH-mediated degradation of a
fraction of the KATs will counteract acetylation. It will be very interest-
ing to see whether also other components of these multi-protein com-
plexes can be targeted by SIAH proteins. Although SIAH proteins are
primarily found in the cytoplasm, a fraction localizes to the nucleus to
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Fig. 7. Phosphorylation of SIAH2 augments its ability to degrade KATs. (A) Tip60 was expressed alone or together with increasing amounts of SIAH2 wildtype, SIAH2 5A or the
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pressive NCoR complex silences the activity of unliganded nuclear re-
ceptors and is tightly associated with HDAC3 activity, thus leading to
local histone deacetylation. Also HDAC3 can be degraded by SIAH2
[38], raising the fascinating scenario that SIAH proteins can govern the
general acetylation status by controlling the stabilities of acetylating
and deacetylating protein complexes. These ﬁndings also imply that in-
creased expression of SIAH proteinswhich is seen in breast cancer [9] or
the increased nuclear localization of SIAH as it occurs in human hepato-
cellular carcinomas [39] may well have a general impact on protein
acetylation and chromatin compaction. Interestingly, the CBP/p300 pro-
teins can be degraded by both SIAH forms, while Tip60 and PCAF are
only sensitive to SIAH2. The molecular basis for this is not understood,
but it seems plausible that differential dimerization and the formation
of SIAH2 homodimers accounts for this speciﬁcity [40].
As SIAH1 and SIAH2 are well-known p53 target genes [10,11,41],
the induced expression of these E3 ligases will have an impact on
the acetylation status of p53. After induction of the early p53 re-
sponse under adverse conditions such as genotoxic stress, the p53
protein can be acetylated which activates DNA-binding and transcrip-
tional activity of p53 [16]. In addition, acetylated p53 is refractory to
ubiquitination, which results in the stabilization of this tumor sup-
pressor [42]. Given the relevance of p53 acetylation for its function,
the acetylation status is regulated by a variety of mechanisms. Oneof the enzymes mediating p53 deacetylation is Sirt1, which can be
stabilized by the ubiquitin-speciﬁc peptidase USP22, one of the 11
death-from-cancer signature genes [43]. USP22-mediated stabiliza-
tion of Sirt1 results in decreased levels of p53 acetylation and conse-
quently in suppression of p53-mediated functions. Another example
comes from the tumor suppressor WTX, which frequently inactivated
in Wilms tumor. Recent evidence shows that WTX enhances binding
of p53 to CBP, consequently increasing CBP-mediated p53 acetylation
and thus increasing p53 function [44].
In conclusion our data suggest that full p53 activation is followed
by the increased synthesis of SIAH proteins. Hierarchical phosphory-
lation of SIAH2 by the p53 kinase HIPK2 further augments its function
as a ubiquitin E3 ligase and will then lead to degradation of the KATs
and impaired p53 acetylation. As SIAH proteins can also degrade the
p53 kinase HIPK2 [12], also the critical p53 Ser46 phosphorylation
will be lost, as schematically depicted in Fig. 7D. These mechanisms
will contribute to dampen the late p53 response and thus help to
avoid prolonged and exaggerated p53 activity.
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